1 – 10 of 62
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Pharmacological modulation of T cell immunity results in long-term remission of autoimmune arthritis
(
- Contribution to journal › Article
- 2018
-
Mark
Tumor Regression and Cure Depends on Sustained Th1 Responses
(
- Contribution to journal › Article
- 2017
-
Mark
T Cell Activation Pathways : B7, LFA-3, and ICAM-1 Shape Unique T Cell Profiles
(
- Contribution to journal › Article
- 2016
-
Mark
Maintenance of the E.coli dcm Methylation of the CMV Promoter, in Contrast to Hypomethylation of the Recognition Sequence of Transcription Factor NFkB in Transfected GBM Cells
(
- Contribution to journal › Article
- 2014
-
Mark
A glioma classification scheme based on coexpression modules of EGFR and PDGFRA
2014) In Proceedings of the National Academy of Sciences of the United States of America 111(9). p.3538-3543(
- Contribution to journal › Article
- 2013
-
Mark
Zebularine induces long-term survival of pancreatic islet allotransplants in streptozotocin treated diabetic rats.
(
- Contribution to journal › Article
- 2012
-
Mark
An epigenetic mechanism for high, synergistic expression of indoleamine 2,3-dioxygenase 1 (IDO1) by combined treatment with zebularine and IFN-γ: Potential therapeutic use in autoimmune diseases.
(
- Contribution to journal › Article
- 2011
-
Mark
Different toxicity profiles for drug-versus radionuclide-conjugated BR96 monoclonal antibodies in a syngeneic rat colon carcinoma model
(
- Contribution to journal › Article
- 2010
-
Mark
Toxicity-Reducing Potential of Extracorporeal Affinity Adsorption Treatment in Combination With the Auristatin-Conjugated Monoclonal Antibody BR96 in a Syngeneic Rat Tumor Model
(
- Contribution to journal › Article
-
Mark
High-Dose Radioimmunotherapy Combined With Extracorporeal Depletion in a Syngeneic Rat Tumor Model
(
- Contribution to journal › Article